H.U. Group Holdings | Sustainability Performance
Operates healthcare-related businesses, including clinical testing, medical systems, and research services, through its group companies.
1950
Japan
5,001 - 10,000 employees
Hospital & Health Care
$1B - 10B in revenue
$10M - 25M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#1049
Overallⓘ#67
in Japanⓘ#8
in Hospital & Health CareⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Financial Data
Business performanceCapital & innovationAnalyst projections
Controversy level
- H.U. Group Holdings (formerly Miraca Holdings), Japanese clinical labs/diagnostics, has faced multiple Japanese FSA enforcement scrutiny over alleged inadequate disclosure of post-COVID Japanese clinical testing volume normalization, plus periodic class actions over alleged inadequate disclosure of customer concentration affecting Japanese institutional shareholders.
